Cellular sources of extracellular matrix in hepatic fibrosis.
about
Extracellular matrix and liver diseaseFrom tissue mechanics to transcription factors.Effects of p-CREB-1 on transforming growth factor-β3 auto-regulation in hepatic stellate cellsLiver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cellsThe hard life of soft cells.Association of hepatitis C virus with insulin resistance: evidences from animal studies and clinical studiesTranscriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGECharacterization of transcriptional modules related to fibrosing-NAFLD progression.Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models.The function of integrin-linked kinase in normal and activated stellate cells: implications for fibrogenesis in wound healingCol1A1 production and apoptotic resistance in TGF-β1-induced epithelial-to-mesenchymal transition-like phenotype of 603B cells.Fibronectin: functional character and role in alcoholic liver disease.Diseased renal glomeruli are getting soft. Focus on "Biophysical properties of normal and diseased renal glomeruli"Protection against Acute Hepatocellular Injury Afforded by Liver Fibrosis Is Independent of T Lymphocytes.Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis.Matrix stiffness promotes cartilage endplate chondrocyte calcification in disc degeneration via miR-20a targeting ANKH expression.Smoothened is a master regulator of adult liver repair.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Contribution of Myofibroblasts of Different Origins to Liver FibrosisAryl Hydrocarbon Receptor Activation by TCDD Modulates Expression of Extracellular Matrix Remodeling Genes during Experimental Liver Fibrosis.Delivery and targeting of miRNAs for treating liver fibrosis.Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.Endothelial cell-derived matrix promotes the metabolic functional maturation of hepatocyte via integrin-Src signalling.Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model.Sinusoidal communication in liver fibrosis and regeneration.Basement Membrane Type IV Collagen and Laminin: An Overview of Their Biology and Value as Fibrosis Biomarkers of Liver Disease.Side population in LX2 cells decreased by transforming growth factor-β.Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model.Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cells.Hepatic fibrogenesis and transforming growth factor/Smad signaling activation in rats chronically exposed to low doses of lead.Activated hepatic stellate cells mediate the differentiation of macrophages.The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity.Biliary epithelium: A neuroendocrine compartment in cholestatic liver diseaseA genome-wide association study identifies a susceptibility locus for biliary atresia on 2p16.1 within the gene EFEMP1Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
P2860
Q26823060-B7E37FA4-FC04-44D6-BB38-F2A2B66B846AQ26866255-62D7FF5E-3E19-4CB3-86EF-6FE4F663F373Q28564900-C48F83F0-9E6D-4C83-9999-0EED9179DCBCQ30369750-320F92EE-D2AC-4506-8A05-DBBE8C7A7E6DQ30480676-4CCC16A3-D3F1-4DCC-BA43-52FB8159764FQ30485410-1AF8803C-7BCA-4665-9DE5-BDADC848A13CQ33531797-967EBBAA-22C7-4750-A623-9589194675D0Q33881352-242F633D-1945-4878-B9F1-AC9F807BDE7AQ33952003-BD192BC4-4C7B-40FE-A9C2-14067E2B3B03Q34118683-CAB523E7-76F8-4137-BA97-E8949A806CC6Q34510956-26C2B1A9-9E55-4D8C-8C44-E1B3B882AEC2Q34629775-A5742EE0-27DF-4B5D-8617-F3CFE7B6DF5DQ34717928-78EDA371-924C-4E6E-92C3-8F0EAA6E7E00Q36177168-19728495-5B19-4D6D-B266-F775282AA4D5Q36672445-246A4CF3-DED5-42BF-BAE6-653AE2D2C813Q36698776-0B75EC9A-BF67-4069-8075-4EE4859C358BQ36864767-894A64BC-D979-4F3E-BF83-0781FE1C25E1Q36890924-A3826718-59C5-448D-8022-F0BEBD706AFEQ37121662-8969102F-2C07-4199-9932-2AD65CD35ABCQ37128332-3D85F44F-8521-48C4-9167-685E8D7A83D1Q37273664-598EE1FE-C469-4B37-9405-C887F567F2E4Q38245905-52C47BAA-721A-449E-8DCF-FF9EDFA7F1D9Q38738028-0570A8F4-68F0-4C8B-A680-1A91FBBACB3DQ38805359-1E9B4E47-D72E-47A0-9AAF-BC2B6ECE5933Q38822836-2A0F8DF0-7396-4F5D-B7AE-B6785B3A3B1DQ38827092-9C7826C4-66C9-48FA-9DC0-CD34FD236F0CQ39130543-A021508E-5711-416F-9D14-8D9C11B81253Q39167934-8B3DE91E-8950-4DC7-9ADD-F4A2B1D8450FQ40059303-F1D011CF-1A60-4B8E-9A21-B2C4E3B87E31Q40068189-D86EF7B9-96B2-4E15-93C1-9C73CF4064ECQ40089171-147DD41C-54D2-4AC0-A653-A991F337C956Q41707214-F1F349AA-2C01-4569-9BAC-5360504CA7D9Q44809819-217F7384-3494-479F-B16D-790EBD1DAA4DQ47553075-B8AFCAD8-16EF-470C-A5B5-1F6EE4161F4EQ57109378-30FA85E6-D04A-4728-9734-B115914D7C08Q57112027-5EF7E28A-3ABD-4E02-862C-C15582981AB2Q58754397-25CF67D8-3B79-420D-A2C1-C52063FFEEF5
P2860
Cellular sources of extracellular matrix in hepatic fibrosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Cellular sources of extracellular matrix in hepatic fibrosis.
@en
Cellular sources of extracellular matrix in hepatic fibrosis.
@nl
type
label
Cellular sources of extracellular matrix in hepatic fibrosis.
@en
Cellular sources of extracellular matrix in hepatic fibrosis.
@nl
prefLabel
Cellular sources of extracellular matrix in hepatic fibrosis.
@en
Cellular sources of extracellular matrix in hepatic fibrosis.
@nl
P2860
P1476
Cellular sources of extracellular matrix in hepatic fibrosis.
@en
P2093
Rebecca G Wells
P2860
P304
759-68, viii
P356
10.1016/J.CLD.2008.07.008
P577
2008-11-01T00:00:00Z